Transient tachypnea of the newborn (TTN) is a short-lived condition of fast breathing that affects newborn babies and usually resolves after 3 or 4 days after birth. Though rapid breathing in a ...

Two new studies suggest that nirsevimab (Beyfortus) is 80% to 89% effective in protecting infants from poor respiratory syncytial virus (RSV) outcomes, and a third study ties a federal initiative to ...

The standard treatments for bradycardia in neonatal intensive care units, or NICUs, are methylxanthine drugs (caffeine) and continuous positive airway pressure machines, similar to the CPAP devices ...

Newborn babies who experience low levels of oxygen in their body tissues (hypoxia) due to sleep apnea, for example, tend to develop respiratory problems and hypertension (high blood pressure) in ...